Market Tracker

02/20 3:37am ET

TESARO Inc (NASDAQ:TSRO)

190.36
Delayed Data
As of Feb 17
 +7.80 / +4.27%
Today’s Change
35.50
Today|||52-Week Range
192.43
+41.55%
Year-to-Date
Clovis, Tesaro Soar on Astrazeneca Phase Three News
Feb 17 / TheStreet.com - Paid Partner Content
Here's Why M&A Has Tesaro's Stock Soaring 40% In 2017
Feb 10 / MotleyFool.com - Paid Partner Content
Your Burning Biotech Questions Answered
Feb 17 / TheStreet.com - Paid Partner Content
Why Panera Bread, Tesaro, and Universal Corp. Jumped Today
Feb 08 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close182.56
Today’s open184.47
Day’s range181.01 - 192.43
Volume1,131,524
Average volume (3 months)1,043,670
Market cap$10.2B
Dividend yield--
Data as of 3:59pm ET, 02/17/2017

Growth & Valuation

Earnings growth (last year)-33.19%
Earnings growth (this year)-16.69%
Earnings growth (next 5 years)+152.82%
Revenue growth (last year)--
P/E ratioNM
Price/Sales6,500.72
Price/Book88.26

Competitors

 Today’s
change
Today’s
% change
SGENSeattle Genetics Inc+0.20+0.31%
ALKSAlkermes Plc-0.98-1.76%
PRGOPerrigo Company PLC+1.35+1.62%
JAZZJazz Pharmaceuticals...+0.78+0.57%
Data as of 4:01pm ET, 02/17/2017

Financials

Last reporting dateFebruary 16, 2017
EPS forecast (this quarter)-$1.95
Annual revenue (last year)$317.0K
Annual profit (last year)-$251.4M
Net profit margin-79,308.52%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Lonnie Moulder
President, Chief Operating Officer &
Director
Mary Lynne Hedley
Corporate headquarters
Waltham, Massachusetts

Forecasts